Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu Okamura

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 14, 2025
[A Case of Intraductal Papillary Mucinous Carcinoma with Difficult Preoperative Diagnosis]Narumi Sawamura, Yoshiteru Katsura, Koji Hayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 25, 2026
[A Case of Long-Term Survival after Resection of Postoperative Lung Metastasis from Pancreatic Cancer]Yoshiteru Katsura, Koji Hayashi, Narumi Sawamura, et al.
International Journal of Cancer|May 14, 2009
ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expressionKensuke Kumamoto, Kaori Fujita, Reiko Kurotani, et al.
Journal of the Anus, Rectum and Colon|August 4, 2020
Efficacy of Negative Pressure Wound Therapy Followed by Delayed Primary Closure for Abdominal Wounds in Patients with Lower Gastrointestinal Perforations: Multicenter Prospective StudyHirofumi Ota, Katsuki Danno, Katsuya Ohta, et al.
Oncology Reports|October 2, 2014
Circulating miR-199a-3p as a novel serum biomarker for colorectal cancerRyoji Nonaka, Junichi Nishimura, Yoshinori Kagawa, et al.
Medicine|September 9, 2020
Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: A post hoc analysis of the WJOG4407G phase III studyAyumu Hosokawa, Kentaro Yamazaki, Chu Matsuda, et al.
International Journal of Oncology|March 4, 2014
SCGB2A1 is a novel prognostic marker for colorectal cancer associated with chemoresistance and radioresistanceKoji Munakata, Mamoru Uemura, Ichiro Takemasa, et al.
Cancer Research|April 3, 2004
p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosisS Perwez Hussain, Paul Amstad, Peijun He, et al.
International Journal of Clinical Oncology|March 29, 2020
Phase II study of 5-fluorouracil-leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802)Takashi Ohta, Takeshi Kato, Hisato Kawakami, et al.
Annals of Surgical Oncology|November 14, 2019
Lymph Node Positivity in One-Step Nucleic Acid Amplification is a Prognostic Factor for Postoperative Cancer Recurrence in Patients with Stage II Colorectal Cancer: A Prospective, Multicenter StudyMichio Itabashi, Hirofumi Yamamoto, Naohiro Tomita, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 14, 2025
[A Case of Intraductal Papillary Mucinous Carcinoma with Difficult Preoperative Diagnosis]Narumi Sawamura, Yoshiteru Katsura, Koji Hayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 25, 2026
[A Case of Long-Term Survival after Resection of Postoperative Lung Metastasis from Pancreatic Cancer]Yoshiteru Katsura, Koji Hayashi, Narumi Sawamura, et al.
International Journal of Cancer|May 14, 2009
ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expressionKensuke Kumamoto, Kaori Fujita, Reiko Kurotani, et al.
Journal of the Anus, Rectum and Colon|August 4, 2020
Efficacy of Negative Pressure Wound Therapy Followed by Delayed Primary Closure for Abdominal Wounds in Patients with Lower Gastrointestinal Perforations: Multicenter Prospective StudyHirofumi Ota, Katsuki Danno, Katsuya Ohta, et al.
Oncology Reports|October 2, 2014
Circulating miR-199a-3p as a novel serum biomarker for colorectal cancerRyoji Nonaka, Junichi Nishimura, Yoshinori Kagawa, et al.
Medicine|September 9, 2020
Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: A post hoc analysis of the WJOG4407G phase III studyAyumu Hosokawa, Kentaro Yamazaki, Chu Matsuda, et al.
International Journal of Oncology|March 4, 2014
SCGB2A1 is a novel prognostic marker for colorectal cancer associated with chemoresistance and radioresistanceKoji Munakata, Mamoru Uemura, Ichiro Takemasa, et al.
Cancer Research|April 3, 2004
p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosisS Perwez Hussain, Paul Amstad, Peijun He, et al.
International Journal of Clinical Oncology|March 29, 2020
Phase II study of 5-fluorouracil-leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802)Takashi Ohta, Takeshi Kato, Hisato Kawakami, et al.
Annals of Surgical Oncology|November 14, 2019
Lymph Node Positivity in One-Step Nucleic Acid Amplification is a Prognostic Factor for Postoperative Cancer Recurrence in Patients with Stage II Colorectal Cancer: A Prospective, Multicenter StudyMichio Itabashi, Hirofumi Yamamoto, Naohiro Tomita, et al.
Pageof 11